Starting from this rationale, Yang et al. demonstrated that PD-1, PD-L1, PD-L2 and CTLA4, are aberrantly upregulated in 8–34% of CD34+ AML cells [46]. The gene discussed is PDCD1LG2; the disease is acute myeloid leukemia.